William J. Sandborn

Specialty: Inflammatory Bowel Disease

Location: United States

Tier: ELITE

H-Index: 176

Years Active: 0

Hospital Affiliations

• University of California, San Diego - Faculty

Key Publications

1. "STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD." - Gastroenterology (2021)
2. "Crohn's disease." - Lancet (2012)
3. "Vedolizumab as induction and maintenance therapy for ulcerative colitis." - N Engl J Med (2013)
4. "Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis." - N Engl J Med (2019)
5. "Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses." - Sci Immunol (2020)

Knowledge Graph Relationships

William J. Sandborn is a Inflammatory Bowel Disease specialist affiliated with University of California, San Diego. Authored 5 scholarly articles.